Mechanism of action of somatostatin: an overview of receptor function and studies of the molecular characterization and purification of somatostatin receptor proteins.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Metabolism: Clinical and Experimental

• Publication date

  1990-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0026-0495(90)90214-WPMID 1976223
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular characterization of a functional cDNA encoding the rat substance P receptor.

  1990cited by this paper
• Evidence That Receptor‐Linked G Protein Inhibits Exocytosis by a Post‐Second‐Messenger Mechanism in AtT‐20 Cells

  1990cited by this paper
• Electrophysiological effects of somatostatin-14 and somatostatin-28 on mammalian central nervous system neurons.

  1990cited by this paper
• GE: a GTP-binding protein mediating exocytosis.

  1990cited by this paper
• Somatostatin inhibition of hormone release: effects on cytosolic Ca++ and interference with distal secretory events.

  1990cited by this paper
• Somatostatin action in pituitary cells involves two independent transduction mechanism.

  1990cited by this paper
• Solubilization and immunopurification of a somatostatin receptor from the human gastric tumoral cell line HGT-1.

  1989cited by this paper
• The signal recognition particle receptor mediates the GTP-dependent displacement of SRP from the signal sequence of the nascent polypeptide.

  1989cited by this paper
• Evidence for multiple protein constituents of the somatostatin receptor in pituitary tumor cells: affinity cross-linking and molecular characterization.

  1989cited by this paper
• Purification of a putative brain somatostatin receptor.

  1989cited by this paper
• Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase.

  1989cited by this paper
• Somatostatin-14 and somatostatin-28 induce opposite effects on potassium currents in rat neocortical neurons.

  1989cited by this paper
• Functionally distinct G proteins selectively couple different receptors to PI hydrolysis in the same cell.

  1989cited by this paper
• Distinct subsets of somatostatin receptors on cultured human lymphocytes.

  1989cited by this paper
• Somatostatin receptors on rat cerebrocortical membranes. Structural characterization of somatostatin-14 and somatostatin-28 receptors and comparison with pancreatic type receptors.

  1988cited by this paper
• Characterization of the cyclic AMP-independent actions of somatostatin in GH cells. I. An increase in potassium conductance is responsible for both the hyperpolarization and the decrease in intracellular free calcium produced by somatostatin.

  1988cited by this paper
• Differential regulation of PI hydrolysis and adenylyl cyclase by muscarinic receptor subtypes

  1988cited by this paper
• Somatostatin pretreatment increases the number of somatostatin receptors in GH4C1 pituitary cells and does not reduce cellular responsiveness to somatostatin.

  1988cited by this paper
• Characterization of the cyclic AMP-independent actions of somatostatin in GH cells. II. An increase in potassium conductance initiates somatostatin-induced inhibition of prolactin secretion.

  1988cited by this paper
• Characterization of covalently cross-linked somatostatin receptors in hamster beta cell insulinoma.

  1988cited by this paper
• Distribution of somatostatin receptors in RINm5F insulinoma cells.

  1988cited by this paper
• Peptides derived from cleavage of prosomatostatin at carboxyl- and amino-terminal segments. Characterization of tissue and secreted forms in the rat.

  1988cited by this paper
• Somatostatin receptor subtypes in the clonal anterior pituitary cell lines AtT-20 and GH3.

  1988cited by this paper
• Adrenergic receptors. Models for the study of receptors coupled to guanine nucleotide regulatory proteins.

  1988cited by this paper
• Selective binding of somatostatin-14 and somatostatin-28 to islet cells revealed by quantitative electron microscopic autoradiography.

  1987cited by this paper
• Reconstitution of somatostatin and muscarinic receptor mediated stimulation of K+ channels by isolated GK protein in clonal rat anterior pituitary cell membranes.

  1987cited by this paper
• A guanine nucleotide-binding protein mediates the inhibition of voltage-dependent calcium current by somatostatin in a pituitary cell line.

  1986cited by this paper
• Quantitative in vivo autoradiographic localization of [125I-Tyr11]somatostatin-14- and [Leu8,D-Trp22-125I-Tyr25]somatostatin-28-binding sites in rat brain.

  1986cited by this paper
• Two types of somatostatin receptors differentiated by cyclic somatostatin analogs.

  1985cited by this paper
• Stimulation of adrenocorticotropin secretion from AtT-20 cells by the calcium channel activator, BAY-K-8644, and its inhibition by somatostatin and carbachol.

  1985cited by this paper
• Relationship between receptor binding and biopotency of somatostatin-14 and somatostatin-28 in mouse pituitary tumor cells.

  1985cited by this paper
• Localization and characterization of brain somatostatin receptors as studied with somatostatin-14 and somatostatin-28 receptor radioautography.

  1985cited by this paper
• Somatostatin desensitization in rat anterior pituitary cells.

  1984cited by this paper
• Somatostatin (second of two parts).

  1983cited by this paper
• Somatostatin.

  1983cited by this paper
• Somatostatin analogs: correlation between receptor binding affinity and biological potency in GH pituitary cells.

  1983cited by this paper
• Somatostatin (First of two parts)

  1983cited by this paper
• Polish sciences: Nothing to read

  1982cited by this paper
• Multiple subcutaneous injections of somatostatin induce tachyphylaxis of the suppression of plasma insulin, but not glucagon, in the rat.

  1982cited by this paper
• Receptor binding of somatostatin-28 is tissue specific

  1981cited by this paper
• Characterization of functional receptors for somatostatin in rat pituitary cells in culture.

  1978cited by this paper
• Mechanism of action of somatostatin: Inhibition of ionophore A23187‐induced release of growth hormone from dispersed bovine pituitary cells

  1976cited by this paper
• Somatostatin inhibition of glucose-, tolbutamide-, theophylline, cytochalasin B-, and calcium-stimulated insulin release in monolayer cultures of rat endocrine pancreas.

  1975cited by this paper

• Octreotide

  2025cites this paper
• Efficacy and Safety of Lanreotide Autogel in the Treatment of Clinical Symptoms Associated With Inoperable Malignant Intestinal Obstruction: A Prospective Phase II Study.

  2021cites this paper
• Prolactin and Angiogenesis : Biological Implications of Microheterogeneity Kambadur Muralidhar and Jaeok

  2019cites this paper
• Common tools for pituitary adenomas research: cell lines and primary cells

  2019cites this paper
• Prevention and management of carcinoid crises in patients with high-risk neuroendocrine tumours undergoing peptide receptor radionuclide therapy (PRRT): Literature review and case series from two Australian tertiary medical institutions.

  2018cites this paper
• A Comparative Perspective on Wnt/β-Catenin Signalling in Cell Fate Determination.

  2017cites this paper
• Pasireotide for treating acromegaly

  2016cites this paper
• The Development of Cyclic RGD Peptides Stabilized Through 99mTc/Re(CO)3+

  2015cites this paper
• Somatostatin in in ̄ ammatory bowel disease

  2014cites this paper
• Single-photon emission computed tomography tracers in the diagnostics of neuroendocrine tumors.

  2014cites this paper
• Somatostatin preserved blood brain barrier against cytokine induced alterations: possible role in multiple sclerosis.

  2013cites this paper
• Prolactin and Angiogenesis : Biological Implications of Microheterogeneity Kambadur Muralidhar and

  2013cites this paper
• Prolactin and Angiogenesis: Biological Implications of Microheterogeneity

  2013cites this paper
• New drugs in the therapy of neuroendocrine tumors

  2012cites this paper
• Inhibitory activity of the peptides derived from buffalo prolactin on angiogenesis

  2011cites this paper
• Somatostatin and somatostatin receptors.

  2010cites this paper
• Growth hormone- secreting pituitary adenomas: from molecular basis to treatment options in acromegaly

  2010cites this paper
• Review article: future therapies for management of metastatic gastroenteropancreatic neuroendocrine tumours

  2009cites this paper
• C H A N G E IN SOMATOSTATIN RECEPTOR EXPRESSION AFTER V A S C U L A R INJURY

  2009cites this paper
• Badanie ekspresji podtypów receptora somatostatynowego w ludzkich guzach endokrynnych

  2009cites this paper
• The role of somatostatin analogues in the treatment of neuroendocrine tumours.

  2008cites this paper
• Somatostatin analogues in the control of neuroendocrine tumours: efficacy and mechanisms.

  2008cites this paper
• Somatostatin Receptors in Human Neuroblastoma Cell Lines Identification , Characterization , and Biological Activity of Updated

  2007cites this paper
• Gastrointestinale Hormonsysteme und ihre Regulation

  2006cites this paper
• Somatostatin Treatment Attenuates Proteinuria and Prevents Weight Loss in NZB/W F1 Mice

  2006cites this paper
• Efficacy of octreotide-LAR in dieting women with abdominal obesity and polycystic ovary syndrome.

  2005cites this paper
• Pituitary cell lines and their endocrine applications.

  2004cites this paper
• Somatostatin receptor subtypes: basic pharmacology and tissue distribution.

  2004cites this paper
• Somatostatin receptors and disease : role of receptor subtypes

  2004cites this paper
• Role of Interferon-Alpha 2B and Octreotide in Prevention of Experimentally Induced Corneal Neovascularization in Rats

  2003cites this paper
• Somatostatin, but not somatostatin receptor subtypes 2 and 5 selective agonists, inhibits calcitonin secretion and gene expression in the human medullary thyroid carcinoma cell line, TT.

  2002cites this paper
• Somatostatin receptor subtype 1-selective activation reduces cell growth and calcitonin secretion in a human medullary thyroid carcinoma cell line.

  2002cites this paper
• Somatostatin, but not Somatostatin Receptor Subtypes 2 and 5 Selective Agonists, Inhibits Calcitonin Secretion and Gene Expression in the Human Medullary Thyroid Carcinoma Cell Line, TT

  2002cites this paper
• Comparison of Somatostatin Receptor Expression in Human Gliomas and Medulloblastomas

  2002cites this paper
• Identification of the somatostatin receptor subtypes involved in regulation of growth hormone secretion in chickens.

  2001cites this paper
• Neuro-endocrine-immune axis in human rheumatoid arthritis.

  2000cites this paper
• Somatostatin and its receptor family.

  1999cites this paper
• Regulatory peptides in the urinary bladder of two genera of Antarctic teleosts

  1999cites this paper
• The Therapeutic Value of Somatostatin and Its Analogues

  1999cites this paper
• Quantitation of somatostatin receptor type 2 in neuroendocrine (merkel cell) carcinoma of the skin by competitive RT-PCR

  1999cites this paper
• Effect of Octreotide on experimental corneal neovascularization.

  1999cites this paper
• Functional role of somatostatin receptors in neuroendocrine and immune cells.

  1999cites this paper
• Receptor-mediated Internalization Is Critical for the Inhibition of the Expression of Growth Hormone by Somatostatin in the Pituitary Cell Line AtT-20*

  1999cites this paper
• The role of somatostatin in the pathophysiology of rheumatoid arthritis.

  1998cites this paper
• Somatostatin in lungfish kidney: an immunohistochemical, autoradiographical and in situ hybridisation study.

  1998cites this paper
• Characterization of the promoter region of the human somatostatin receptor subtype 2 gene and localization of sequences required for estrogen-responsiveness.

  1998cites this paper
• Localization of somatostatin receptor genes on mouse chromosomes 2, 11, 12, 15, and 17: correlation with growth QTLs.

  1997cites this paper
• Molecular pharmacology of somatostatin receptor subtypes

  1997cites this paper
• Somatostatin analogs and receptors. Diagnostic and therapeutic applications.

  1997cites this paper
• Somatostatin in inflammatory bowel disease

  1997cites this paper
• Somatostatin inhibits the stimulatory effect of secretin on pancreatic cancer cell growth in vitro

  1997cites this paper
• A comparison of 111In‐octreotide and 67Ga scintigraphy in malignant lymphoma

  1997cites this paper
• Modulation of synovial cell function by somatostatin in patients with rheumatoid arthritis.

  1997cites this paper
• Angiopeptin, a somatostatin analogue, inhibits rat coronary artery and aorta smooth muscle cell proliferation induced by the thromboxane A2 mimetic U46619.

  1997cites this paper
• Coexistence of somatostatin receptor subtypes in the human neuroblastoma cell line LA‐N‐2

  1997cites this paper
• Octreotide.

  1996cites this paper
• Molecular mechanisms of antiproliferative effect of somatostatin: involvement of a tyrosine phosphatase.

  1996cites this paper
• The helix‐loop‐helix transcription factor SEF‐2 regulates the activity of a novel initiator element in the promoter of the human somatostatin receptor II gene.

  1996cites this paper
• Topographic differences in cell populations and insulin secretion in the endocrine pancreas of the toad Bufo arenarum.

  1996cites this paper
• Somatostatin receptors and disease: role of receptor subtypes.

  1996cites this paper
• Metabolic Regulation of Growth Hormone Secretagogue Gene Expression

  1996cites this paper
• Somatostatin receptor scintigraphy in the diagnosis of neuroendocrine gastroenteropancreatic tumors.

  1996cites this paper
• Induction of a negative autocrine loop by expression of sst2 somatostatin receptor in NIH 3T3 cells.

  1996cites this paper
• Quantitation of somatostatin receptor type 2 gene expression in neuroblastoma cell lines and primary tumors using competitive reverse transcription-polymerase chain reaction.

  1996cites this paper
• Somatostatin receptor manipulation.

  1996cites this paper
• Somatostatin receptors in prostate tissues and derived cell cultures, and the in vitro growth inhibitory effect of BIM-23014 analog.

  1995cites this paper
• Somatostatin analogs: clinical application in relation to human somatostatin receptor subtypes.

  1995cites this paper
• A tyrosine phosphatase is associated with the somatostatin receptor.

  1995cites this paper
• Dexamethasone regulates somatostatin receptor subtype messenger ribonucleic acid expression in rat pituitary GH4C1 cells.

  1995cites this paper
• The somatostatin receptor family.

  1995cites this paper
• An in vitro model suitable for studying insulin secretion in amphibians.

  1995cites this paper
• Release of somatostatin, neurotensin and vasoactive intestinal peptide upon inhibition of gastric acid secretion by duodenal acid and hyperosmolal solutions in the conscious rat.

  1995cites this paper
• Somatostatin receptors: clinical implications for endocrinology and oncology.

  1995cites this paper
• Characterization of the proximal promoter region of the rat somatostatin receptor gene, SSTR4.

  1995cites this paper
• Somatostatin-induced modulation of inflammation in experimental arthritis.

  1995cites this paper
• Somatostatin and its receptor. Introduction.

  1995cites this paper
• COMMENTARY SOMATOSTATIN ANALOGS: CLINICAL APPLICATION IN RELATION TO HUMAN SOMATOSTATIN RECEPTOR SUBTYPES

  1995cites this paper
• Iodine-123-Tyr-3-octreotide uptake in pancreatic endocrine tumors and in carcinoids in relation to hormonal inhibition by octreotide.

  1994cites this paper
• Human somatostatin receptor, SSTR2, is coupled to adenylyl cyclase in the presence of Gi alpha 1 protein.

  1994cites this paper
• Up-regulation of somatostatin receptors by epidermal growth factor and gastrin in pancreatic cancer cells.

  1994cites this paper
• Somatostatin regulates somatostatin receptor subtype mRNA expression in GH3 cells.

  1994cites this paper
• Distribution of Somatostatin Receptors 1, 2 and 3 mRNA in Rat Brain and Pituitary

  1994cites this paper
• Identification, characterization, and biological activity of somatostatin receptors in human neuroblastoma cell lines.

  1994cites this paper
• Characterization of cloned human somatostatin receptor SSTR5.

  1994cites this paper
• Co-purification of a protein tyrosine phosphatase with activated somatostatin receptors from rat pancreatic acinar membranes.

  1994cites this paper
• Molecular cloning, functional characterization, and chromosomal localization of a human somatostatin receptor (somatostatin receptor type 5) with preferential affinity for somatostatin-28.

  1994cites this paper
• Octreotide exerts different effects in vivo and in vitro in Cushing's disease.

  1994cites this paper
• Somatostatin in human follicular fluid.

  1994cites this paper
• Interferon-alpha-2b alone and combined with octreotide in primary carcinoid cell-cultures.

  1994cites this paper
• Pituitary and hypothalamic somatostatin receptor subtype messenger ribonucleic acid expression in the food-deprived and diabetic rat.

  1994cites this paper
• [Genetic engineering in the bacterial synthesis of somatostatin].

  1994cites this paper
• Expression of multiple somatostatin receptor genes in AtT-20 cells. Evidence for a novel somatostatin-28 selective receptor subtype.

  1994cites this paper
• Relative potencies of the somatostatin analogs octreotide, BIM-23014, and RC-160 on the inhibition of hormone release by cultured human endocrine tumor cells and normal rat anterior pituitary cells.

  1994cites this paper
• All five cloned human somatostatin receptors (hSSTR1-5) are functionally coupled to adenylyl cyclase.

  1994cites this paper
• Transforming growth factor-alpha and epidermal growth factor inhibit gastric acid secretion and stimulate release of somatostatin and neurotensin in the conscious rat.

  1994cites this paper
• Receptors for gut regulatory peptides.

  1994cites this paper
• 4 Receptors for gut regulatory peptides

  1994cites this paper
• Ionic Mechanisms Governing the Control of Growth Hormone Secretion by Somatostatin

  1994cites this paper
• Somatostatin: physiology and clinical applications.

  1994cites this paper
• Peptidergic Regulation of Gastric Acid Secretion

  1993cites this paper